BEST PRACTICE ANTICOAGULATION PROCESS FOR DEEP VEIN THROMBOSIS THERAPY REDUCE ADMISSIONS

• At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
• Type: Poster
• By: JENSEN, Melanie (Advent Health, United States)
• Co-author(s): Melanie Jensen: Pharmacy, Advent Health, Orlando, United States
  Oscar Santalo: Pharmacy, Advent Health, Orlando, United States
  
• Abstract:

  Background

  For deep vein thrombosis (DVT), the average length of stay (LOS) is 5.8 days and the mean acute-care hospital costs are $5,779 per visit.  Early-directed protocols with a direct oral anticoagulant (DOAC) for DVT management for early discharge have been shown to prevent patient admissions, improve patient follow-up, and decrease hospital..

The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login